Zeng Weiwei, Lao Sixian, Guo Yi, Wu Yufeng, Huang Min, Tomlinson Brian, Zhong Guoping
The Second People's Hospital of Longgang District, Shenzhen, China.
Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.
Front Nutr. 2022 May 31;9:907986. doi: 10.3389/fnut.2022.907986. eCollection 2022.
Research has shown that green tea catechins may influence the activity of drug metabolizing enzymes and drug transporters. We examined whether epigallocatechin-3-gallate (EGCG) affected the pharmacokinetics and pharmacodynamics of bisoprolol in rats.
A sensitive, specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established for the quantitative determination of EGCG and bisoprolol. The pharmacokinetic parameters of EGCG and bisoprolol in Sprague-Dawley (SD) rats were analyzed using non-compartmental methods with the aid of the computer program WinNolin. Blood pressure (BP) of spontaneously hypertensive rats (SHRs) was monitored by the tail-cuff method. Bisoprolol was given as single doses of 10 mg/kg with or without EGCG 100 mg/kg by gavage or by intravenous injection.
Intake of EGCG with bisoprolol by gavage significantly reduced the C (mean C from 2012.31 to 942.26 ng/mL, < 0.05) and increased the T (mean T from 0.5 to 0.83 h, < 0.01) for bisoprolol. After intravenous injection, EGCG significantly increased the apparent volume of distribution of bisoprolol (mean Vz/F from 1629.62 to 2473.27 mL/Kg, < 0.05) and tended to increase the clearance. The absolute bioavailability of bisoprolol was reduced from 92.04 to 66.05% in rats when bisoprolol was administered with EGCG. Heart rate reduction was less in SHRs when EGCG was given by gavage with bisoprolol whereas BP reduction occurred more rapidly.
This study showed that the simultaneous administration of EGCG by gavage at a dose of 100 mg/kg was associated with decreased C and increased T of bisoprolol, and the Vz/F of bisoprolol was increased when administered with EGCG by intravenous injection in SD rats. Moreover, the early heart rate reduction with bisoprolol was attenuated and BP reduction occurred earlier when EGCG was given with bisoprolol by gavage in SHRs.
研究表明,绿茶儿茶素可能会影响药物代谢酶和药物转运体的活性。我们研究了表没食子儿茶素 -3- 没食子酸酯(EGCG)是否会影响大鼠中比索洛尔的药代动力学和药效学。
建立了一种灵敏、特异的液相色谱 - 串联质谱(LC-MS/MS)方法,用于定量测定EGCG和比索洛尔。借助计算机程序WinNolin,采用非房室模型方法分析了EGCG和比索洛尔在斯普拉格 - 道利(SD)大鼠中的药代动力学参数。通过尾套法监测自发性高血压大鼠(SHR)的血压。比索洛尔以10mg/kg的单剂量通过灌胃或静脉注射给药,同时或不同时给予100mg/kg的EGCG。
灌胃给予EGCG和比索洛尔时,比索洛尔的C显著降低(平均C从2012.31降至942.26ng/mL,P<0.05),T增加(平均T从0.5小时增至0.83小时,P<0.01)。静脉注射后,EGCG显著增加了比索洛尔的表观分布容积(平均Vz/F从1629.62增至2473.27mL/Kg,P<0.05),并倾向于增加清除率。当比索洛尔与EGCG一起给药时,大鼠中比索洛尔的绝对生物利用度从92.04%降至66.05%。灌胃给予EGCG和比索洛尔时,SHR中比索洛尔降低心率的作用减弱,而血压降低发生得更快。
本研究表明,在SD大鼠中,灌胃给予100mg/kg剂量的EGCG与比索洛尔的C降低和T增加相关,静脉注射EGCG与比索洛尔一起给药时,比索洛尔的Vz/F增加。此外,在SHR中,灌胃给予EGCG和比索洛尔时,比索洛尔早期降低心率的作用减弱,血压降低更早出现。